|
YTHDF3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.21709999999042E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.848300E-04 |
| Normal-vs-Stage2 |
8.241800E-02 |
| Normal-vs-Stage3 |
1.332240E-02 |
| Normal-vs-Stage4 |
1.51058999999787E-05 |
| Stage1-vs-Stage2 |
8.676200E-01 |
| Stage1-vs-Stage3 |
6.462400E-01 |
| Stage1-vs-Stage4 |
6.050500E-02 |
| Stage2-vs-Stage3 |
6.460000E-01 |
| Stage2-vs-Stage4 |
2.129800E-01 |
| Stage3-vs-Stage4 |
4.463200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.78710000000271E-05 |
| Normal-vs-AfricanAmerican |
9.2786999972283E-08 |
| Normal-vs-Asian |
6.561800E-01 |
| Caucasian-vs-AfricanAmerican |
1.051970E-02 |
| Caucasian-vs-Asian |
5.266800E-01 |
| AfricanAmerican-vs-Asian |
4.362300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.97169999999392E-06 |
| Normal-vs-Female |
8.840300E-03 |
| Male-vs-Female |
6.346400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.959200E-04 |
| Normal-vs-Age(41-60Yrs) |
4.383500E-04 |
| Normal-vs-Age(61-80Yrs) |
3.365300E-04 |
| Normal-vs-Age(81-100Yrs) |
1.100210E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.972600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.418200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.549400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.912400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.487000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.810200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.025200E-01 |
| Normal-vs-Grade 2 |
6.062200E-02 |
| Normal-vs-Grade 3 |
3.55099999960196E-07 |
| Normal-vs-Grade 4 |
9.84650028179601E-10 |
| Grade 1-vs-Grade 2 |
7.747400E-01 |
| Grade 1-vs-Grade 3 |
1.474000E-01 |
| Grade 1-vs-Grade 4 |
1.050420E-02 |
| Grade 2-vs-Grade 3 |
2.279500E-02 |
| Grade 2-vs-Grade 4 |
1.555640E-04 |
| Grade 3-vs-Grade 4 |
2.721600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.525800E-02 |
| Normal-vs-ccB subtype |
6.563600E-03 |
| ccA subtype-vs-ccB subtype |
2.257400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.141300E-03 |
| Normal-vs-N1 |
1.211980E-01 |
| N0-vs-N1 |
7.332000E-01 |
|
|
